Liberty Star Minerals received approval from the Arizona State Land Department to conduct geologic field operations including surface mapping, outcrop sampling, and panning over a 40-acre area in the Tombstone Mining District through November 2027. This approval allows the company to systematically explore and identify high-grade gold sources at its Red Rock Canyon Gold Project, building on previous promising assay results. The program aims to refine drilling targets by linking samples to specific zones, advancing the company's efforts in a significant mineral-rich region. Fieldwork is set to begin immediately, with updates expected as results come in.
Liberty Star Minerals' recent approval for geologic field operations provides context for readers interested in mining activities. For readers following Basic Materials, here is Pluang's market snapshot as of Nov 10, 2026 19:43 WIB: out of 83 priced US stocks, 24 rose and 59 fell. Notable movers include CDE at USD 15.96 with a -2.98% change, AUGO at USD 84.41 with a -2.97% change, and FSM at USD 9.78 with a -2.88% change.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
